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Macrophage apoptosis and the ability of phagocytes to clear these
apoptotic cells are important processes in advanced atherosclerosis.
Phagocytic clearance not only disposes of dead cells but usually elic-
its an anti-inflammatory response. To study this process in a model
of advanced lesional macrophage death, macrophages rendered
apoptotic by free cholesterol loading (FC-AMs) were incubated
briefly with fresh macrophages (“phagocytes”). FC-AMs were
promptly ingested by the phagocytes, which was dependent upon
actin polymerization and the phagocyteMer receptor. Surprisingly,
this brief exposure to FC-AMs triggered amodest proinflammatory
response in the phagocytes: tumor necrosis factor- (TNF-) and
interleukin (IL)-1 were induced, whereas the levels of transform-
ing growth factor- and IL-10 were not increased. This response
required cell contact between the FC-AMs and phagocytes but not
FC-AM ingestion. TNF- and IL-1 induction required one or
more proteins on the FC-AM surface and was dependent on signal-
ing through extracellular signal-regulated kinase-1/2mitogen-acti-
vated protein kinase and nuclear factor-B in the phagocytes.
TNF- production was markedly greater when Mer-defective
phagocytes were used, indicating that Mer attenuated the inflam-
matory response. Interestingly, a more typical anti-inflammatory
response was elicited when phagocytes were exposed to macro-
phages rendered apoptotic by oxidized low density lipoprotein or
UV radiation. Thus, the proinflammatory milieu of advanced ath-
erosclerotic lesions may be promoted, or at least not dampened, by
contact between FC-induced apoptoticmacrophages andneighbor-
ing phagocytes prior to apoptotic cell ingestion.
Macrophages in advanced atherosclerotic lesions accumulate
excess unesterified, or “free,” cholesterol (FC)2 (1–3). FC accumula-
tion is a potent inducer of inflammatory cytokines and apoptosis in
macrophages (4–6), which represent two important features of
advanced, unstable plaques (6, 7). The molecular mechanisms of
FC-induced inflammation and apoptosis in cultured macrophages
and the consequences of inflammation in atherogenesis have been
studied in depth (4, 8–11). However, the significance of macrophage
apoptosis in atherosclerosis development remains unclear. During
the initial or intermediate stages of atherosclerosis, accelerated apo-
ptosis and rapid removal of the apoptotic cells by neighboring
macrophage phagocytes appear to reduce the number of atherogenic
and inflammation-prone macrophages within the plaque and there-
fore decelerate lesion progression (12–14). On the other hand,
macrophage apoptosis in advanced lesions has been implicated in
the generation of necrotic cores, a “graveyard of dead macrophages”
that is thought to promote plaque instability (6, 15–17). The differ-
ence may lie not only in accelerated apoptosis in late lesions, but perhaps
even more so in defective phagocytic clearance of apoptotic cells (14,
18–21). When apoptotic cells are not rapidly cleared, they undergo post-
apoptotic necrosis, which could contribute to lesional necrosis.
Although defective clearance of apoptotic macrophages by a sub-
population of incompetent phagocytes in advanced atheromata likely
contributes to necrotic core formation, it is almost certain that other
phagocytes in advanced lesions are competent and can ingest apoptotic
macrophages. According to the literature, this event should at least
partially counterbalance the effect of the incompetent phagocytes for
two reasons: postapoptotic necrosis is prevented, and the competent
phagocytes should elicit an anti-inflammatory response upon exposure
to apoptotic cells (18, 19). The latter point is based upon a number of
studies showing that apoptotic cells induce in phagocytes the secretion
of TGF- and IL-10, which have anti-inflammatory roles in atheroscle-
rosis (22–27) and suppress the secretion of proinflammatory cytokines,
such as TNF- (28, 29).
To model the latter scenario, we set up an experimental system in
which FC-induced apoptotic macrophages were exposed briefly to
competent phagocytes to enable ingestion, and then the noningested
apoptotic cells were removed. We found that this brief exposure to
FC-induced apoptotic cells did not lead to the typical anti-inflammatory
response in the phagocytes but rather induced the production of the
proinflammatory cytokines TNF- and IL-1. Thus, even in the case
where FC-induced apoptoticmacrophages are ingested rapidly by com-
petent phagocytes, as likely occurs to some degree in advanced athero-
sclerotic lesions, inflammation is not suppressed.
EXPERIMENTAL PROCEDURES
Materials—Chemical reagents were from Sigma unless specified
below. Low density lipoprotein (LDL; d 1.020–1.063 g/ml) was isolated
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from fresh human plasma by preparative ultracentrifugation as
described previously (30). Acetyl-LDL was prepared by reaction of LDL
with acetic anhydride (31). Oxidized LDL was from Biomedical Tech-
nologies, Inc. Compound 58035 (3-[decyldimethylsilyl]-N-[2-(4-meth-
ylphenyl)-1-phenylethyl] propanamide), an inhibitor of acyl-CoA:cho-
lesterol O-acyltransferase (ACAT), was generously provided by Dr.
JohnHeider, formerly of Sandoz, Inc. (East Hanover, NJ) (32). U18666A
was from Biomol Research Laboratories, Inc. SB203580, SB202474, and
PD98059 were from EMDBiosciences. PS1145 was a generous gift from
Millennium Pharmaceuticals (33). Antibodies against p38, phospho-p38,
ERK1/2, phospho-ERK1/2, and IB- were from Cell Signaling Technol-
ogy. Anti-nucleophosmin was from Zymed Laboratories, Inc. Anti--tu-
bulin and anti--actin were from Santa Cruz Biotechnologies, Inc.
Mice—Female C57BL6/J mice from Jackson Laboratories, 8–10
weeks of age, were used in this study. Mertk mice on the C57BL6/J
background were created as described previous (34).Myd88/ mice
on theC57BL6/J backgroundwere generously provided byDrs. Douglas
Golenbock (University of Massachusetts) and Mason Freeman (Har-
vard Medical School) (35). Cd36/ mice on the C57BL6/J back-
ground were generously provided by Dr. Kathryn J. Moore (Harvard
Medical School) (36). Mice processing the loxP-flanked LRP/CD91
were provided by Dr. Joachim Herz (University of Texas Southwestern
Medical Center) (37). Themicewere crossed to LysM-Cremice, and the
offspring were bred to homozygosity at the loxP-flanked LRP locus.
Elicitation and Culturing of Mouse Peritoneal Macrophages—Meth-
yl-BSA (mBSA)- or concanavalin A-elicited macrophages (4, 11) were
used in most of the studies and yielded similar results. mBSA-elicited
macrophages were generated by intraperitoneal injection of mBSA in
mice previously immunized with this antigen. 2 mg/ml mBSA in 0.9%
saline was emulsified in an equal volume of complete Freund’s adjuvant
(CFA, DIFCO). Mice were immunized intradermally with 100 l emul-
sion. 14 days later, the immunization protocol was repeated except
incomplete Freund’s adjuvant was used instead of complete Freund’s
adjuvant. 7 days later, themice were injected intraperitoneal with 0.5ml
of phosphate-buffered saline containing 100 g mBSA. 4 days later,
macrophageswere harvested by peritoneal lavage. ConcanavalinA-elic-
ited macrophages were obtained from mice that were injected intrap-
eritoneal with 0.5 ml of phosphate-buffered saline containing 40 g of
concanavalin A. Macrophages were harvested 3 days later by peritoneal
lavage. Thioglycollate-elicited or resident macrophages were used as
phagocytes in some experiments. Thioglycollate-elicited macrophages
were obtained frommice that were injected intraperitoneally with 1 ml
of 3.8% thioglycollate broth.Macrophageswere harvested 4 days later by
peritoneal lavage (38). Residentmacrophages were harvested by peritoneal
lavagewithout anyprevious stimulation.Thecellswere cultured inDulbec-
co’s modified Eagle’s medium (DMEM) supplemented with 10% heat-in-
activated fetalbovineserum,100units/mlpenicillin/streptomycin, and20%
L-cell-conditionedmedium for 24–48 h until confluence.
Generation of Apoptotic Cells—FC-induced apoptotic macrophages
(FC-AMs) were generated by incubating the cells with 50 g/ml acetyl-
LDL and 10 g/ml of the ACAT inhibitor 58035 for 16–20 h. Oxidized
LDL-induced apoptotic macrophages were generated by incubating the
cells with 100 g/ml oxidized LDL for 24–30 h. UV-induced apoptotic
macrophages were generated by radiating the cells for 10–15 min (254
nm, 20 J/cm2), followed by culturing the cells for an additional 2–3 h.
Apoptosis was confirmed by annexin V staining. In a typical experi-
ment, a population of macrophages with 30–40% apoptosis (annexin
V-positive) and less than 5% necrosis (PI-positive) were collected and
exposed to phagocytes for 30 min. There was no significant increase in
necrosis (i.e. PI-positivity) during this 30-min period. To generate FC-
AM-conditioned medium, the FC-loading medium was removed, and
the FC-AMs were gently washed twice and then incubated in fresh
medium for 1 h. The medium was then centrifuged at 14,000 rpm for 5
min before use. To generate membranes, FC-AMs or control macro-
phages were subjected to three cycles of rapid freezing and thawing.
Limited proteolysis was done by treating FC-AMs with 0.1–1.0 mg/ml
trypsin in DMEM at 37 °C for 20 min and then washing the cells with
DMEM containing 10% fetal bovine serum six times.
Phagocytosis—Apoptotic cells were added to a monolayer of fresh
macrophages (“phagocytes”) at a ratio of 5:1 (apoptotic cells:phago-
cytes). In a typical phagocytosis experiment, the apoptotic cells were
labeled with Alexa Fluor 488- or 594-conjugated annexin V (Molecular
Probes). After incubation for 15–30 min with the phagocytes, non-
ingested apoptotic cells were removed by vigorous washing. The phago-
cyteswere then fixedwith 4%paraformaldehyde and viewed by confocal
fluorescence microscopy. Additional experiments to confirm internal-
ization of the apoptotic cells are presented under “Results.” To examine
the cellular responses in the phagocytes following contact with apop-
totic cells, noningested apoptotic cells were removed by vigorous wash-
ing after a 30-min incubation as above, and the phagocytes were incu-
bated in fresh media for the indicated times.
Cytokine Production—Phagocytes were incubated with apoptotic
cells for 30min. Noningested apoptotic cells were removed, and phago-
cytes were cultured in fresh media for various times. At the end of
incubation, themedia were centrifuged at 14,000 rpm for 5min, and the
supernatant fractions were stored in aliquots at 80 °C. Cytokine levels
in the media were determined by high sensitivity ELISA analysis, which
was conducted by the Cytokine Core Laboratory (Baltimore, MD).
RT-QPCR—Total RNA was extracted from macrophages using the
RNeasy kit fromQiagen. cDNAwas synthesized from 4g of total RNA
using oligo(dT) and Superscript II (Invitrogen). 0.5 l of cDNA was
subjected to QPCR amplification using Taqman universal PCR master
mix (Applied Biosystems). The forward and reverse primers for TGF-
were TGACGTCACTGGAGTTGTACGG and GGTTCATGTCAT-
GGATGGTGC, respectively, and the probe was 6FAM-TTCAGCGC-
TCACTGCTCTTGTGACAG. The forward and reverse primers for
TNF-wereCGGAGTCCGGGCAGGTandGCTGGGTAGAGAAT-
GGATGAACA, respectively, and the probe was 6FAM-CTTTGGAG-
TCATTGCTCTGTGAAGGGAATG. The forward and reverse prim-
ers for IL-1 were CAACCAACAAGTGATATTCTCCATG and
GATCCACACTCTCCAGCTGCA, respectively, and the probe was
6FAM-CTGTGTAATGAAAGACGGCACACCCACC. 36B4was used
as the internal control. The forward and reverse primers for 36B4 were
AGATGCAGCAGATCCGCAT and GTTCTTGCCCATCAGCACC,
respectively, and the probewasCAL-CGCTCCGAGGGAAGGCCG.The
reactions were run on an MX4000 multiplex quantitative PCR system
(Stratagene). The thermal profile settingswere 50 °C for 2min, 95 °C for 10
min, followed by 45 cycles at 95 °C for 15 s and then 60 °C for 1 min.
Immunoblotting—Whole cell lysates were prepared by homogeniz-
ing the cells into 1 sample loading buffer from Bio-Rad. Nuclear
extracts were prepared using theNuclear Extraction kit fromPanomics,
Inc. Cell extracts were electrophoresed on 4–20% gradient SDS-poly-
acrylamide gels and transferred to 0.22-m nitrocellulose membranes.
The membranes were blocked in Tris-buffered saline, 0.1% Tween 20
(TBST) containing 5% (w/v) nonfat milk at room temperature for 1 h.
The membranes were then incubated with the primary antibody in
TBST containing 5% (w/v) nonfat milk or 5% BSA at 4 °C overnight,
followed by incubation with the appropriate secondary antibody cou-
pled to horseradish peroxidase. Proteins were detected by ECL chemi-
luminescence (Pierce).
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Statistics—Data are presented as the mean  S.E. To quantify the
percentage of phagocytes positive for uptake, n  10 fields of cells at a
magnification of 20 were studied. For RT-PCR and ELISA data, n  3
separate samples for each condition were examined. Statistical signifi-
cance was determined using Student’s t test with unequal variance.
RESULTS
FC-induced Apoptotic Macrophages Are Removed Promptly by
Phagocytes—To examine how phagocytes ingest and respond to FC-
induced apoptotic macrophages, we added these cells to a monolayer of
fresh macrophages for 15–60 min, followed by removal of noningested
cells by vigorous rinsing. To avoid confusion, we refer to the FC-in-
duced apoptotic macrophages as FC-AMs and the phagocytic macro-
phages as phagocytes. To begin, we examined whether FC-AMs were
substrates for phagocytic ingestion by adding Alexa Fluor 594-conju-
gated annexin V-labeled FC-AMs (red) to a monolayer of CellTracker
Green-labeled phagocytes (green). Using confocal microscopy, we
found that ingestion of FC-AMs by the phagocytes, indicated by red
inclusions in green cells, occurred as early as 15 min after incubation
(Fig. 1A, left panel). The typical percentage of phagocytes positive for
ingesting FC-AMs cells was 20–30%, compared with 40–50% for UV-
irradiated Jurkat cells, which are often used in phagocytosis studies of
FIGURE 1. FC-AMs are ingested by control or
cholesterol-loaded phagocytic macrophages
via a process dependent on actin polymeriza-
tion. A, CellTracker Green-labeled phagocytes
(green) were preincubated with control medium, 1
M cytochalasin D (cytoD), or 100 nM latrunculin A
(LA) for 30 min. The phagocytes were then incu-
bated for an additional 30 min in the presence of
the aforementioned reagents with FC-AMs that
had been prelabeled with Alexa Fluor 594-annexin
V (red). Noningested cells were removed by thor-
ough washing, and the phagocytes were fixed and
viewed by confocal fluorescence microscopy. B,
FC-AMs were prelabeled with Alexa Fluor 488-an-
nexin V (green) and then added to unlabeled
phagocytes for 30 min. Noningested FC-AMs were
removed by washing as above. The phagocytes
were then incubated in fresh medium for 30 min,
followed by staining with Alexa Fluor 594-annexin
V (red). The left panel is the phase image, the middle
panel is the green-filter image, and the right panel
is the red-filter image. C, FC-loaded macrophages
(left pair of images) or non-FC-loaded control
macrophages (right pair of images) were stained
with CellTracker Green and then incubated with
unlabeled phagocytes for 30 min. Noningested
cells were removed as above. In each pair of
images, the left image is phase, and the right image
is fluorescence. D, phagocytes were preincubated
with control medium (control phagocytes), 50
g/ml acetyl-LDL (CE-phagocytes), or 50 g/ml
acetyl-LDL plus 10 g/ml ACAT inhibitor 58035
(FC-phagocytes) for 12 h. The phagocytes were
then incubated with FC-AMs for 30 min and
washed as above. The percentage of phagocytes
that ingested FC-AMs was quantified.
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this nature. Careful examination of the confocal micrographs showed
that the rinsing protocol removed bound but noningested FC-AMs, and
so only ingestion is being assayed in this protocol. Preincubation of the
phagocytes with cytochalasin D or latrunculin A, compounds that block
phagocytosis by disrupting actin polymerization, completely inhibited
apoptotic cell uptake (Fig. 1A,middle and right panels).
Ingestion of FC-AMs, rather than simple binding of the cells to the
phagocytes, was also demonstrated by a sequential labeling protocol:
FC-AMs labeled with Alexa Fluor 488-conjugated annexin V (green)
were added to phagocytes as above. After noningested cells were
removed, phagocytes were incubated in freshmedia for 30min and then
stained with Alexa Fluor 594-conjugated annexin V (red). The second
stain would label any FC-AMs that were not ingested, as demonstrated
by a control experiment in which FC-AMs that were not exposed to
phagocytes were labeled with both green and red annexin V using this
sequential procedure (data not displayed). As shown in Fig. 1B, very
little red stainingwas observed, indicating that almost all of the FC-AMs
were completely internalized by the phagocytes.
The FC-loaded macrophages added to the phagocytes contained a
proportion of viable macrophages as well as FC-AMs (i.e. not all of the
macrophages are rendered apoptotic by FC loading (8)). To confirm
that the viable cells were removed efficiently from the phagocytemono-
layer using our rinsing protocol, we labeled populations of FC-loaded
and non-FC-loaded macrophages (i.e. 100% viable) with CellTracker
Green. These cells were then added to unlabeled phagocytes and sub-
jected to the incubation and rinsing protocol described above. In the
FC-loaded population, there was abundant association of green-labeled
cells with phagocytes (Fig. 1C, left pair of images). In contrast, the
unloaded (“control”) population of macrophages did not label the
phagocytes (Fig. 1C, right pair of images). Thus, viable macrophages are
removed efficiently by the rinsing protocol used in our phagocytosis
assay. The data also show that labeling FC-loaded macrophages with
CellTracker Green yields phagocytosis results similar to those observed
when the FC-AMs are labeled with fluorescent annexin V.
As mentioned above, the experimental system used herein was
designed as a model of those phagocytes in advanced lesions which
remain competent to clear apoptotic macrophages. However, there is
evidence that some of the phagocytes in advanced atherosclerotic
lesions are relatively inefficient at clearing apoptotic macrophages (14,
20). In this context, we asked whether two types of alterations ofmacro-
phages that occur in advanced lesions, namely, cholesteryl ester loading
(“foam cells”) and predeath FC loading, would alter the ability of phago-
cytes to ingest FC-AMs. To test this point, phagocytes were first incu-
bated for 12 h in the absence or presence of acetyl-LDL or acetyl-LDL
plus the ACAT inhibitor 58035 to generate control phagocytes, foam
cell phagocytes, or preapoptotic FC-loaded phagocytes, respectively.
The phagocytes were then exposed to FC-AMs as above and assayed for
apoptotic cell ingestion. Interestingly, these lipid-laden phagocytes
were able to ingest FC-AMs as efficiently as control phagocytes that did
not contain excess cholesterol (Fig. 1D). Thus, to the extent that certain
phagocytes in advanced lesions are unable to clear apoptotic cells, cho-
lesteryl ester accumulation or predeath FC loading does not appear to
be the cause of the phagocytic defect.
Mer Plays a Critical Role in the Uptake of FC-AMs—A number of
phagocyte receptors have been implicated in apoptotic cell recognition
and uptake, including the membrane tyrosine kinase Mer, CD36, v3
integrin, LRP, and perhaps a heretofore unidentified receptor that rec-
ognizes phosphatidylserine (PS) (39, 40). Apoptotic cell removal in vivo
is defective inMer-deficient (mertk) mice (41) but appears to be normal
in other receptor knock-out mouse models. We explored the potential
role of these receptors in phagocytosis of FC-AMs by using the follow-
ing manipulations: (a) preincubation of phagocytes with PS-liposomes
FIGURE 2. Internalization of FC-AMs by phago-
cytes is highly dependent on the phagocyte
Mer receptor. Phagocytosis of FC-AMs was quan-
tified under the following experimental condi-
tions of phagocyte alteration. A, phagocytes were
preincubated with control medium, PS- or phos-
phatidylcholine (PC)-containing liposomes (100
M), the integrin-specific blocking peptide RGDS,
or the inactive form RGGS (1 mg/ml) for 30 min.
The phagocytes were then incubated for an addi-
tional 30 min with FC-AMs in the presence of the
aforementioned reagents. B, wild-type (WT) or
Cd36/ phagocytes were incubated with
FC-AMs for 30 min. C, wild-type, LRPflox, or LRPflox-
LysMCre phagocytes were incubated with FC-AMs
for 30 min. D, wild-type or mertk phagocytes were
incubated with FC-AMs for 30 min. Asterisk, p 
0.005.
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or with the integrin-specific blocking peptide RGDS (Fig. 2A); or (b)
using phagocytes from Cd36/ mice, macrophage-specific LRP-de-
ficient mice, ormertkmice, which have a mutation in Mer that renders
the receptor dysfunctional (34) (Fig. 2, B–D). The data show that inter-
rupting interactions through PS, RGDS-integrins, LRP, and CD36 had
minimal effects on uptake of FC-AMs, even though we were able to
reproduce the inhibitory effect of the above manipulations using phag-
ocytosis systems reported previously (42, 43 and data not displayed). On
the other hand, when the phagocytes were from mertkmice, uptake of
FC-AMs was suppressed by60% (Fig. 2D). Thus, Mer plays an impor-
tant role in the uptake of FC-AMs by phagocytes.
Phagocytes Exposed to FC-AMs Produce a Number of Proinflamma-
tory Cytokines and Fail to Induce TGF- and IL-10—Phagocytosis of
apoptotic T cells and neutrophils by macrophages induces the produc-
tion of the anti-inflammatory cytokine TGF-, which activates signal-
ing pathways leading to transcriptional suppression of proinflammatory
cytokines (28, 29). We examined whether FC-AMs would also elicit
anti-inflammatory responses in phagocytes. Surprisingly, we found
modest increases in the mRNA and protein levels of the proinflamma-
tory cytokines TNF- and IL-1, whereas TGF- mRNA and protein
were not increased (Fig. 3, black bar in each graph). IL-10 mRNA was
also unchanged, and IL-10 protein was below the detection limit of the
ELISA (data not shown). Time course studies indicated that the increase
in TNF- and IL-1 mRNAwas initiated at 4 h postphagocytosis and
was maximal at 6–10 h postphagocytosis. Accumulation of TNF-
and IL-1 protein in themedia was observed at10 h postphagocytosis
and reached a plateau at 18–20 h. Incubation of the phagocytes with
viable cholesteryl ester-loadedmacrophages or FC-loaded preapoptotic
macrophages did not affect the cytokine profile (Fig. 3A, last two bars in
each graph).
FIGURE 3. Induction of TNF- and IL-1 mRNA and protein in phagocytes after brief contact with FC-AMs. A, phagocytes were incubated for 30 min with FC-AMs, cholesteryl
ester-loaded macrophages (CE-Ms), or preapoptotic FC-loaded macrophages (FC-preApo Ms). The phagocytes were washed thoroughly and then incubated in fresh medium for
8 h. Total RNA was extracted and processed by RT-PCR for the indicated cytokine mRNAs. B, phagocytes were incubated with FC-AMs or UV radiation-induced apoptotic macrophages
(UV-AMs) for 30 min. The phagocytes were washed thoroughly and then incubated in fresh medium for 18 h. The culture medium was collected and subjected to ELISA analysis for
the indicated cytokines. Asterisks, p  0.01; double asterisks, p  0.005 compared with control phagocytes (white bar).
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FC-AMs altered a number of other inflammatory responses in phago-
cytes that, based on in vivo studies, predict a net increase in inflamma-
tion (44–46). For example, there was a 2-fold elevation in prostaglandin
E2 and IL-6. Moreover, granulocyte macrophage colony-stimulating
factor, a molecule that can induce inflammation as well as leukocyte
differentiation (46), was markedly suppressed by exposure of phago-
cytes to apoptotic Jurkat cells but not at all by FC-AMs. These findings,
together with the data on TNF-, IL-1, TGF-, and IL-10, indicate a
global inflammatory response in phagocytes exposed to FC-AMs.
To test specificity, we asked whether ingestion of macrophages ren-
dered apoptotic by either oxidized LDL or UV radiation would also
trigger a proinflammatory response in the phagocytes. We carefully
adjusted the conditions of oxidized LDL or UV treatment so that the
degree of apoptosis by these two methods was similar to that of FC-
AMs, i.e. 30–40% as indicated by annexin V positivity. We found that
the phagocytes were able to ingest all three types of apoptotic macro-
phages with the same efficiency. However, phagocytosis of oxidized
LDL-induced apoptotic macrophages (not shown) or UV radiation-in-
duced apoptotic macrophages (Fig. 3B, gray bar in each graph) resulted
in a typical anti-inflammatory response. These data suggest that the
proinflammatory response seen with FC-AMs is unique to this type of
apoptotic macrophage. We next considered the possibility that the
proinflammatory response to FC-AMs was related to the state of acti-
vation of the phagocytic macrophages, which were elicited by either
intraperitoneal injection of concanavalin A or by immunization with
methyl-BSA (see “Experimental Procedures”). However, similar results
were found using resident macrophages or thioglycollate-elicited
macrophages as the phagocytes (data not shown). Therefore, the proin-
flammatory response in phagocytes after contact with FC-AMs is inde-
pendent of the activation state of the phagocytes.
FC-AMMembranes, through One or More Cell Surface Proteins, Can
Trigger the Induction of TNF- and IL-1 in Phagocytes without the
Need for FC-AM Ingestion—To test whether the induction of TNF-
and IL-1 described here can be triggered without engulfment of FC-
AMs, phagocytes were treated with latrunculin A prior to incubation
with the FC-AMs to block apoptotic cell engulfment (see Fig. 1A). As
shown in Fig. 4A, TNF- induction was not diminished in the presence
of latrunculin A, indicating that internalization of the FC-AMs is not
necessary for induction of the inflammatory response. The induction of
IL-1 by FC-AMs was also not affected by latrunculin A (data not
shown).
Because ingestion of FC-AMs is not required, the induction of TNF-
and IL-1 in the phagocytes could be mediated by a soluble factor
secreted from the FC-AMs or by a molecule on the surface of the FC-
AMs. To distinguish between these two possibilities, we incubated
phagocytes with FC-AM-conditioned media or with membranes
derived from FC-AMs. For the latter purpose, FC-AMs were rapidly
frozen and thawed for three cycles to lyse the cells without disrupting
the overall orientation of cell surface molecules. As shown in Fig. 4B,
FC-AM-derived membranes were able to elicit the same cytokine
FIGURE 4. Internalization of FC-AMs is not required for the induction of TNF- and IL-1 in phagocytes. A, phagocytes were preincubated for 30 min with medium alone or
medium containing 100 nM latrunculin A (LA) and then incubated for an additional 30 min with FC-AMs in the absence or presence of latrunculin A. The phagocytes were washed
thoroughly and then incubated for 8 h in fresh medium. Total RNA was extracted and processed by RT-PCR for TNF- mRNA. In another set of experiments, the culture medium was
collected 18 h later and subjected to ELISA analysis for TNF- protein. B, phagocytes were incubated for 30 min FC-AMs, FC-AM-conditioned medium, membranes from FC-AMs, or
membranes from control macrophages (cont M-membrane). The membranes were prepared by three cycles of freezing-thawing the cells. The phagocytes were washed thoroughly
and then incubated for 18 h in fresh medium. The culture medium was collected and subjected to ELISA analysis for the indicated cytokines. C, FC-AMs were incubated with the
indicated concentrations of trypsin in DMEM at 37 °C for 20 min and then rinsed thoroughly with DMEM and 10% fetal bovine serum. The trypsin-treated FC-AMs were then incubated
with phagocytes for 30 min. The phagocytes were washed thoroughly and then incubated in fresh medium for 8 h. Total RNA was extracted and processed by RT-QPCR for the
indicated cytokine mRNAs.
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response as intact FC-AMs,whereas FC-AM-conditionedmedia had no
effect. In contrast, membranes generated from viable macrophages
failed to trigger the cytokine response. Furthermore, brief treatment of
FC-AMs with trypsin decreased their ability to induce the cytokine
response in phagocytes in a dose-dependent manner (Fig. 4C). These
important data suggest that one or more proteins on the surface of
FC-AMs are necessary for triggering the induction of TNF- and IL-1
in the phagocytes.
The Induction of TNF- and IL-1 in Phagocytes Exposed to FC-AMs
Requires neither LRP nor the TLR Adaptor Myd88 but Is Attenuated by
Mer—LRP, despite its lack of a role in FC-AM internalization (above), or
Toll-like receptors (TLR) 2 and 4 might mediate the cytokine response
in phagocytes exposed to FC-AMs (47–49). However, we found that the
TNF- response to FC-AMs was not inhibited in phagocytes from
either macrophage-specific LRP-deficient mice or from mice deficient
inMyD88, an adaptor necessary for a number of proinflammatoryTLR2
andTLR4 signaling pathways (50) (data not shown). Because proinflam-
matory signaling by necrotic cells and endotoxin signaling require
MyD88 (49), the negative Myd88/ data indicate that the cytokine
response elicited by FC-AMs is not the result of either a small percent-
age of necrotic cells in the FC-AMpopulation or endotoxin contamina-
tion in our experimental system.
Although we have emphasized that phagocytes exposed to FC-
AMs do not undergo a typical anti-inflammatory response, the
actual level of induction of TNF- and IL-1 was modest. In this
context, previous reports have shown that the engagement of Mer
attenuates LPS-stimulated TNF- production in macrophages (34).
We therefore considered the possibility that Mer, in addition to
mediating FC-AM uptake, may also play a role in dampening the
TNF- response in phagocytes exposed to FC-AMs. As shown in Fig.
5, TNF- mRNA and protein production in mertk phagocytes
exposed to FC-AMs were substantially higher than those from wild-
type phagocytes, indicating that Mer lessens the phagocyte inflam-
matory response. Because Mer-mediated internalization of FC-AMs
is not needed for the cytokine response (above), these data suggest
that the highest level of inflammation would occur under conditions
in whichMer function is suboptimal, which might occur in advanced
atherosclerotic lesions (see “Discussion”).
Intracellular Signaling Pathways Implicated in Triggering the Induc-
tion of TNF- and IL-1 in Phagocytes Exposed to FC-AMs—We dem-
onstrated recently that FC loading of macrophages induces the pro-
duction of two proinflammatory cytokines, TNF- and IL-6, but not
IL-1, prior to the onset of apoptosis (4). Mechanistic studies
revealed that cholesterol trafficking to the endoplasmic reticulum
(ER) is an essential event in FC-induced inflammation. The fact that
phagocytes do not need to internalize FC-AMs for the TNF- and
IL-1 response suggested that the FC-to-ER pathway was not
involved. Nonetheless, we tested this point by using two strategies to
specifically block cholesterol trafficking to the ER in the phagocytes:
the use of phagocytes frommice with a heterozygous mutation in the
cholesterol-trafficking protein NPC1, and incubation of wild-type
phagocytes with nanomolar concentrations of the amphipathic
amine U18666A (10, 51). As shown in Fig. 6A, incubating the phago-
cytes with 70 nM U18666A did not affect TNF- and IL-1 produc-
tion, and similar results were obtained when Npc1 phagocytes
were used (data not shown). These data indicate that the TNF- and
IL-1 response is independent of intracellular cholesterol trafficking
to the ER in the phagocytes, which is consistent with the finding that
FC-AM uptake is not needed for the response to occur.
Sustained activation of p38, ERK1/2 and JNK1/2 MAP kinases are
necessary for the induction of TNF- and/or IL-6 in FC-loaded
macrophages (4). To test the role of theseMAP kinases in the current
model, we assayed their activation and causative roles in TNF- and
IL-1 production in phagocytes following exposure to FC-AMs. As
shown in Fig. 6B, p38 and ERK1/2 were transiently activated 4 h
after phagocytosis. In contrast, JNK1/2 phosphorylation was not
detected (data not shown). The role of p38 and ERK1/2 signaling in
mediating TNF- and IL-1 production in the phagocytes was eval-
uated using specific inhibitors of these two MAP kinases. As shown
in Fig. 6C, at concentrations known to block their target kinase activ-
ities completely, the ERK1/2 inhibitor PD98059 completely sup-
pressed FC-AM-induced TNF- and IL-1 production in the phago-
cytes. In contrast, the p38 inhibitor SB203580 or its inactive form
SB202474 had no effect. A more detailed examination of PD98059
dose response showed that the inhibitory effect of this drug on cyto-
kine induction took place at concentrations that blocked ERK1/2
phosphorylation (Fig. 6D). Thus, the ERK1/2 signaling pathway is
involved in the induction of TNF- and IL-1 in phagocytes after
their contact with FC-AMs.
Activation of the transcription factor NF-B has been implicated
in the transcriptional regulation of cytokines in a wide variety of
systems, including FC-loading of macrophages (4). We therefore
explored the possible involvement of the NF-B pathway in FC-AM-
induced TNF- and IL-1 production in phagocytes. Both degrada-
tion of the NF-B inhibitory protein IB- and accumulation of p65
NF-B in the nucleus were detected at 6 h postphagocytosis (Fig. 7,
A and B), indicating that NF-B is activated in phagocytes exposed to
FIGURE 5. Induction of TNF- in phagocytes exposed to FC-AMs is attenuated by
Mer. Wild-type (WT) and mertk phagocytes were incubated for 30 min with FC-AMs. The
phagocytes were washed thoroughly and then incubated for 8 or 18 h in fresh medium.
The 8-h cells were processed for TNF- RT-QPCR, and the medium from the 18-h cells
were subjected to TNF- ELISA.
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FC-AMs. Most importantly, a specific IB kinase inhibitor, PS1145
(33), significantly suppressed FC-AM-induced TNF- and IL-1
mRNA. Cytokine suppression by PS1145 occurred in a dose-depend-
ent manner that paralleled the decrease in nuclear p65 (Fig. 7C).
Thus, NF-B activation plays a role in the transcriptional regulation
of TNF- and IL-1 induced by contact of phagocytes with FC-AMs.
FIGURE 6. TNF- and IL-1 production in phagocytes exposed to FC-AMs requires ERK1/2 MAP kinase signaling but not cholesterol trafficking to the ER. A, phagocytes were
incubated for 30 min with FC-AMs in the absence or presence of 70 nM U18666A. The phagocytes were washed thoroughly and then incubated in fresh medium in the absence or
presence of U18666A for 18 h. The culture medium was collected and subjected to ELISA analysis for the indicated cytokines. B, phagocytes exposed to FC-AMs for 30 min as above
were incubated in fresh medium for the indicated times. Total cell lysates were subjected to SDS-PAGE followed by immunoblotting for phosphorylated and total p38 and ERK1/2.
C, phagocytes were incubated for 30 min with the FC-AMs in the absence or presence of the ERK inhibitor PD98059 (10 M), the p38 inhibitor SB203580, or its inactive analog
SB202474 (10 M). The phagocytes were washed thoroughly and then incubated in fresh medium in the absence or presence of the above inhibitors for 18 h. The culture medium was
collected and subjected to ELISA analysis for the indicated cytokines. D, phagocytes were incubated 30 min with FC-AMs in the presence of the indicated concentration of PD98059.
The phagocytes were washed thoroughly and then incubated in fresh medium in the presence of the inhibitor. One set of phagocytes was incubated for 5 h, and the cells were lysed
and subjected to SDS-PAGE followed by immunoblotting for phosphorylated and total ERK1/2. Another set of phagocytes was incubated for 8 h, and total RNA was extracted and
processed by RT-QPCR for the indicated cytokine mRNAs.
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DISCUSSION
Although macrophage apoptosis occurs throughout the course of
atherogenesis, recent in vivo studies suggest that the consequences of
macrophage apoptosis are different in early and advanced lesions (14).
In early lesions, where macrophage apoptosis is almost certainly not
induced by FC loading, the net effect of this event appears to be a
decrease in lesion cellularity and no evidence of increased inflammation
(12–14). The most likely explanation is that phagocytic clearance of
early lesional apoptotic macrophages is efficient and results in an anti-
inflammatory response that is typical when phagocytes ingest apoptotic
cells. Indeed, we found that macrophages rendered apoptotic by one
possible inducer of cell death in early lesions, oxidized LDL, does not
elicit a proinflammatory response in phagocytes. In late lesions, how-
ever, in vitro and in vivo data support a model in which defective phag-
ocytosis of apoptoticmacrophages results in postapoptoticmacrophage
necrosis, the precursor of the necrotic core, and a heightened state of
inflammation (14, 20, 52–54).
Nonetheless, given the large number of macrophage phagocytes in
late lesions and the fact that cholesterol loading does not impair their
ability to clear apoptotic cells, it is likely that ingestion of apoptotic
macrophages does occur to some degree in these advanced plaques.We
therefore wondered to what extent the competent subpopulation of
phagocytes in advanced lesions could counterbalance the effect of the
defective subpopulation of phagocytes. In theory, a potent anti-inflam-
matory response by these competent phagocytes, as predicted by previ-
ous studies examining phagocytic uptake of apoptotic cells (28, 29),
might partially negate the proinflammatory effect of necrosis and other
processes in late lesions. However, the data in this report, which are
summarized in Table 1, refute this idea: the typical anti-inflammatory
response does not result when phagocytes are exposed to macrophages
rendered apoptotic by a mechanism that is likely to occur in advanced
plaques.
The consequences of the proinflammatory response observed after
contact between FC-AMs and phagocytes raise important mechanistic
issues. We initially considered the possibility that the cytokines were
simply left over from the FC-AMs themselves, which secrete abundant
amounts of TNF- and IL-6 (see below and Ref 4). However, our mech-
anistic data indicate that this is not the case. First, IL-1 was produced
only after FC-AMs were added to the phagocytes, not by the FC-AMs
themselves. Second, mRNA as well as protein levels for TNF- and
IL-1 were elevated well after the phagocytes had ingested the FC-AMs
and the noningested FC-AMs had been removed. Third, induction of
TNF- and IL-1 in the phagocytes was mediated by intracellular sig-
naling pathways distinct from those in FC-loaded macrophages (4). For
example, blocking p38 signaling abolished TNF- production in FC-
loaded macrophages but had no effect in the phagocytes exposed to
FIGURE 7. TNF- and IL-1 production in phagocytes exposed to FC-AMs requires
NF-B activation. A, phagocytes exposed to FC-AMs for 30 min were incubated in fresh
medium for the indicated times. Total cell lysates were subjected to SDS-PAGE followed by
immunoblotting for IB-. -Actin was used as loading control. B, phagocytes exposed to
FC-AMs for 30 min were incubated in fresh medium for the indicated times. Nuclear extracts
were prepared and subjected to SDS-PAGE followed by immunoblotting for p65 NF-B, the
nuclei protein nucleophosmin, and the cytosolic protein -tubulin (absence of -tubulin
signal is an indication of the purity of the nuclear extract). C, phagocytes were incubated for
30 min with the FC-AMs in the absence or presence of the IB kinase inhibitor PS1145 (2 or 10
M). The phagocytes were washed thoroughly and then incubated in fresh medium in the
absence or presence of the inhibitor for 8 h. Nuclear extracts were prepared from one set of
cells and subjected to SDS-PAGE followed by immunoblotting for p65 NF-B and nucleo-
phosmin. Another set of cells was subjected to total RNA extraction and processed by RT-
QPCR for the indicated cytokine mRNAs.
TABLE 1
Summary of interactions of FC-AMs with phagocytes
The data in this report suggest two types of interactions between FC-AMs and
phagocytes: cell-cell contact mediated by one or more cell surface proteins on the
FC-AMs, and engagement of the phagocyte Mer receptor by FC-AMs. The former
interaction is responsible for the induction of TNF- and IL-1 through ERK1/2
and NF-B activation and is not dependent upon ingestion of the FC-AMs. Further
evidence that this interaction results in an overall proinflammatory response is that
prostaglandin E2 and IL-6 are also induced, granulocyte macrophage colony-stim-
ulating factor is not suppressed, and TGF- and IL-10 are not increased. The inter-
action through Mer has two consequences: actin-dependent ingestion of FC-AMs
and attenuation of the TNF- response. The effect ofMer engagement on the other
cytokines mentioned above was not examined. For details, see text.
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FC-AMs. For these reasons, we conclude that TNF- and IL-1 are
induced in the phagocytes themselves.
Althoughwe donot yet know the detailed signalingmechanism, cyto-
kine induction is NF-B- and ERK1/2-dependent and requires cell con-
tact between the FC-AMs and the phagocytes but not ingestion of FC-
AMs. The fact that limited proteolysis of FC-AM membranes
diminishes their ability to elicit the proinflammatory response in the
phagocytes indicates that one or more cell surface proteins from the
FC-AMs are necessary for the signaling pathways in phagocytes (Table
1). Because the activation of NF-B and ERK1/2 and the induction of
TNF- and IL-1 occurred several hours after the initial FC-AM-phag-
ocyte contact, it is likely that these events are induced secondarily by an
as-yet unidentified intermediary signaling cascade. Such an intermedi-
ary signaling cascade might occur entirely intracellularly in a delayed
manner or involve paracrine/autocrine factors secreted by the phago-
cytes in response to the initial FC-AM-phagocyte contact. In the con-
text of this latter possibility, we collectedmedium from phagocytes that
had been briefly challenged by FC-AMs and added it to fresh macro-
phages, but no inflammatory response was induced. However, a puta-
tive inducing factormight be difficult to identify in conditionedmedium
if it is very labile or rapidly sequestered (i.e. taken out of solution) by
cells.
The one receptor thatwe have shown to be involved in the interaction
of FC-AMs with phagocytes is the cell surface tyrosine kinaseMer. Mer
plays at least two roles in our system: ingestion of FC-AMs and modu-
lation of the proinflammatory response (Table 1). Both roles have been
demonstrated previously in other cell culture models and, most impor-
tantly, in vivo. For example, mice with deficient Mer activity have evi-
dence of defective phagocytic clearance of apoptotic thymocytes and a
heightenedTNF- response to endotoxin challenge (34, 41). Themech-
anisms of these effects are not completely understood, but Mer activa-
tion elicits changes in the cytoskeleton which are likely to be important
in phagocytosis (55, 56), andMer engagement inhibits the NF-B path-
way (34). Another interesting question is howMer recognizes apoptotic
cells. Previous studies have suggested that theMer ligand Gas6 binds to
externalized PS on apoptotic cells and bridges these cells to the Mer
receptor on phagocytes (57). If this process were occurring in our sys-
tem, it is unclear why PS-containing vesicles did not compete for Gas6-
apoptotic cell interaction and thereby inhibit phagocyte ingestion of
FC-AMs. Nonetheless, to the extent that Gas6 may be necessary for
proper Mer function, our data suggest that a relative deficiency of Gas6
in advanced atherosclerotic lesions could further heighten the inflam-
matory response. In this context, vascular smoothmuscle cells appear to
be themajor source of Gas6 in lesions (58), and vulnerable plaques have
a deficiency of smooth muscles in areas of plaque disruption (59).
Finally, another possible consequence of Mer engagement is protection
of phagocytes from apoptosis (60), which may be important in main-
taining the viability of phagocytes in the face a large and potentially
cytotoxic FC load.
The work herein has emphasized a specific scenario relevant to
advanced atherosclerosis in which apoptotic cells elicit a proinflamma-
tory response in phagocytes. Are there other scenarios in late lesions
which may be anti-inflammatory? Although the role of oxidized LDL-
induced macrophage apoptosis in late lesions is not known, our data
would suggest that phagocytosis of macrophages rendered apoptotic by
this means may elicit the typical anti-inflammatory response. Likewise,
it is possible that phagocytosis of macrophagesmade apoptotic by other
means, as well as ingestion of apoptotic smoothmuscle cells, could elicit
an anti-inflammatory response in phagocytes. Another important con-
sideration is related to our previous finding that FC-loaded macro-
phages secrete large amounts of TNF- and IL-6 over time. In one
scenario, these cytokines might further enhance an inflammatory
response in the phagocytes. However, it is also possible that neighboring
macrophages might actually dampen the TNF-/IL-6 response by FC-
loaded macrophages. In the experimental system used in the current
study, which was designed to model rapid and efficient clearance of
apoptotic cells, the FC-AMs were removed rapidly by either phagocytic
ingestion or, for those FC-AMs not ingested, by our postingestion rins-
ing protocol. Therefore, there was not enough time for accumulation of
cytokines secreted by the FC-loaded macrophages, and so the experi-
mental system used here would not address the consequences or fate of
cytokines secreted over time by FC-loadedmacrophages. In this regard,
future studies will be needed to model another likely scenario in
advanced lesions, namely, prolonged exposure of macrophages to non-
ingested FC-loaded macrophages. In all likelihood, the situation in vivo
is likely to be complex, with several scenarios occurring simultaneously.
Therefore, the net effect of late lesional macrophage apoptosis and
phagocytosis in vivo will require genetic manipulations that alter these
events in advanced plaques of experimental animals.
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